These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32387252)

  • 1. Feasibility of intracoronary nicorandil for inducing hyperemia on fractional flow reserve measurement: Comparison with intracoronary papaverine.
    Matsumoto H; Mikuri M; Masaki R; Tanaka H; Ogura K; Arai T; Sakai R; Oishi Y; Okada N; Shinke T
    Int J Cardiol; 2020 Sep; 314():1-6. PubMed ID: 32387252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive value of nicorandil on ATP for further inducing hyperemia in patients with an intermediate coronary artery stenosis.
    Kobayashi Y; Okura H; Neishi Y; Higa T; Kobayashi Y; Uemura S; Yoshida K
    Coron Artery Dis; 2017 Mar; 28(2):104-109. PubMed ID: 27611876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of additional intracoronary nicorandil administration during fractional flow reserve measurement with intravenous adenosine 5'-triphosphate infusion.
    Takami H; Sonoda S; Muraoka Y; Sanuki Y; Kashiyama K; Fukuda S; Oginosawa Y; Tsuda Y; Araki M; Otsuji Y
    J Cardiol; 2017 Jan; 69(1):119-124. PubMed ID: 26947100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postocclusional Hyperemia for Fractional Flow Reserve After Percutaneous Coronary Intervention.
    Kawase Y; Omori H; Kawasaki M; Tanigaki T; Hirata T; Okamoto S; Ota H; Kikuchi J; Okubo M; Kamiya H; Hirakawa A; Suzuki T; Matsuo H
    Circ Cardiovasc Interv; 2017 Dec; 10(12):. PubMed ID: 29246913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility and safety of intracoronary nicorandil infusion as a novel hyperemic agent for fractional flow reserve measurements.
    Kato D; Takashima H; Waseda K; Kurita A; Kuroda Y; Kosaka T; Kuhara Y; Ando H; Maeda K; Kumagai S; Sakurai S; Suzuki A; Toda Y; Watanabe A; Sato S; Fujimoto M; Mizuno T; Amano T
    Heart Vessels; 2015 Jul; 30(4):477-83. PubMed ID: 24748047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of caffeine on fractional flow reserve values measured using intravenous adenosine triphosphate.
    Nakayama M; Chikamori T; Uchiyama T; Kimura Y; Hijikata N; Ito R; Yuhara M; Sato H; Kobori Y; Yamashina A
    Cardiovasc Interv Ther; 2018 Apr; 33(2):116-124. PubMed ID: 28110424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Efficacy of Intracoronary Papaverine After Nicorandil Administration for Safe and Optimal Fractional Flow Reserve Measurement.
    Inoue K; Sonoda S; Naka Y; Okabe H; Setoyama K; Miura T; Anai R; Araki M; Kataoka M
    Int Heart J; 2021 Sep; 62(5):962-969. PubMed ID: 34544970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of combined administration of intracoronary papaverine plus intravenous adenosine 5'-triphosphate in assessment of fractional flow reserve.
    Nishi T; Kitahara H; Iwata Y; Fujimoto Y; Nakayama T; Takahara M; Sugimoto K; Kobayashi Y
    J Cardiol; 2016 Dec; 68(6):512-516. PubMed ID: 26811149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracoronary and intravenous adenosine 5'-triphosphate, adenosine, papaverine, and contrast medium to assess fractional flow reserve in humans.
    De Bruyne B; Pijls NH; Barbato E; Bartunek J; Bech JW; Wijns W; Heyndrickx GR
    Circulation; 2003 Apr; 107(14):1877-83. PubMed ID: 12668522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility and Validity of Intracoronary Administration of Nicorandil Alone for the Measurement of Fractional Flow Reserve in Patients With Intermediate Coronary Stenosis.
    Ishibuchi K; Fujii K; Otsuji S; Takiuchi S; Hasegawa K; Tamaru H; Ishii R; Yasuda S; Nakabayashi S; Yamamoto W; Kusumoto H; Taniguchi Y; Kakishita M; Shimatani Y; Higashino Y
    Circ J; 2019 Sep; 83(10):2010-2016. PubMed ID: 31413232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness and safety of intracoronary administration of nicorandil for evaluating fractional flow reserve in Japanese patients.
    Tanaka N; Takahashi Y; Ishihara H; Kawakami T; Ono H
    Clin Cardiol; 2015 Jan; 38(1):20-4. PubMed ID: 25626396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variability of fractional flow reserve according to the methods of hyperemia induction.
    Lim WH; Koo BK; Nam CW; Doh JH; Park JJ; Yang HM; Park KW; Kim HS; Takashima H; Waseda K; Amano T; Kato D; Kurita A; Oi M; Toyofuku M; van Nunen L; Pijls NH
    Catheter Cardiovasc Interv; 2015 May; 85(6):970-6. PubMed ID: 25413590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous nicorandil versus adenosine for fractional flow reserve measurement: a crossover, randomized study.
    Nishi T; Kitahara H; Fujimoto Y; Nakayama T; Nagashima K; Hanaoka H; Kobayashi Y
    Heart Vessels; 2018 Dec; 33(12):1570-1575. PubMed ID: 29858919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and safety of intracoronary papaverine, alprostadil, and high dosages of nicorandil and adenosine triphosphate for measurement of the index of coronary microcirculatory resistance in a pig model.
    Duan T; Zhang J; Xiang D; Song R; Kong R; Xu D
    Adv Clin Exp Med; 2019 Oct; 28(10):1409-1418. PubMed ID: 31638745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility and safety of intracoronary nicorandil as a hyperemic agent for the measurement of fractional flow reserve.
    Chhabria R; Mehta NP; Jain N; Handa SR; Mehta AB
    Indian Heart J; 2020; 72(6):603-605. PubMed ID: 33357653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insufficient adenosine-induced hyperemia is a major determinant of discordance between non-hyperemic pressure ratio and fractional flow reserve.
    Matsumoto H; Higuchi S; Tanaka H; Masaki R; Kondo S; Tsujita H; Shinke T
    Sci Rep; 2023 Jan; 13(1):729. PubMed ID: 36639567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-induced Hyperemia as an Alternative to Drug-induced Hyperemia in the Evaluation of the Fractional Flow Reserve in Coronary Lesions.
    Shiode N; Okimoto T; Tamekiyo H; Kawase T; Yamane K; Kagawa Y; Fujii Y; Ueda Y; Hironobe N; Kato Y; Hayashi Y
    Intern Med; 2017; 56(3):253-257. PubMed ID: 28154267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of caffeine on intravenous adenosine-induced hyperemia in fractional flow reserve measurement.
    Matsumoto H; Nakatsuma K; Shimada T; Ushimaru S; Mikuri M; Yamazaki T; Matsuda T
    J Invasive Cardiol; 2014 Nov; 26(11):580-5. PubMed ID: 25363999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of caffeine intake on intravenous adenosine-induced fractional flow reserve.
    Kasumi I; Fujii K; Satoru O; Shin T; Katsuyuki H; Hiroto T; Rui I; Shingo Y; Sho N; Wataru Y; Hirofumi K; Yusuke T; Mikio K; Yuji S; Yorihiko H
    J Cardiol; 2020 Nov; 76(5):472-478. PubMed ID: 32532583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of increasing dose of intracoronary adenosine on peak hyperemia duration during fractional flow reserve assessment.
    Verdoia M; Erbetta R; Sagazio E; Barbieri L; Negro F; Suryapranata H; Kedhi E; De Luca G;
    Int J Cardiol; 2019 Jun; 284():16-21. PubMed ID: 30293665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.